Gregory Weinhoff M.'s Insider Trades & SAST Disclosures
Gregory Weinhoff M.'s most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 11,494 Ordinary Shares done at an average price of $15.2 . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gregory Weinhoff M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals p... | M. Weinhoff Gregory | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 25 Feb 2025 | 11,494 | 134,021 | - | 15.2 | 175,270 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 100,000 | 100,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. | 01 Feb 2025 | 14,267 | 145,515 | - | 16.9 | 241,398 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 16.47 per share. | 27 Jan 2025 | 11,742 | 159,782 | - | 16.5 | 193,429 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.35 per share. | 31 Dec 2024 | 11,742 | 171,524 | - | 16.4 | 191,982 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.04 per share. | 26 Dec 2024 | 10,000 | 183,266 | - | 17.0 | 170,399 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2024 | 10,000 | 95,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 26 Dec 2024 | 10,000 | 193,266 | - | 3.9 | 38,500 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory Weinhoff M. | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 25 Nov 2024 | 10,000 | 193,266 | - | 3.9 | 38,500 | Ordinary Shares |
| Centessa Pharmaceuticals p... | M. Weinhoff Gregory | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.66 per share. | 25 Nov 2024 | 10,000 | 183,266 | - | 17.7 | 176,601 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory Weinhoff M. | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 10,000 | 105,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.38 per share. | 25 Oct 2024 | 11,742 | 183,266 | - | 15.4 | 180,628 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.79 per share. | 30 Sep 2024 | 11,742 | 195,008 | - | 15.8 | 185,406 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.69 per share. | 25 Sep 2024 | 16,619 | 206,750 | - | 15.7 | 260,724 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 10 Sep 2024 | 30,000 | 253,369 | - | 5.8 | 175,200 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 30,000 | 584,321 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 10 Sep 2024 | 30,000 | 223,369 | - | 17 | 510,000 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 09 Sep 2024 | 25,000 | 248,369 | - | 5.8 | 146,000 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 25,000 | 614,321 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 09 Sep 2024 | 25,000 | 223,369 | - | 15 | 375,000 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.29 per share. | 22 Aug 2024 | 17,802 | 223,369 | - | 12.3 | 218,792 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.17 per share. | 22 Aug 2024 | 12,198 | 241,171 | - | 12.2 | 148,430 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 30 Jun 2024 | 11,742 | 253,369 | - | 9.0 | 106,030 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.30 per share. | 31 Mar 2024 | 11,742 | 265,111 | - | 11.3 | 132,685 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 125,000 | 125,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 31,250 | 288,347 | - | 0 | Ordinary Shares | |
| Centessa Pharmaceuticals p... | Gregory M. Weinhoff | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 01 Feb 2024 | 11,494 | 276,853 | - | 8.2 | 94,136 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges